razoxane has been researched along with Recrudescence in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Trnĕný, M | 1 |
Benesová, V; Boudová, L; Cahová, S; Dvoráková, D; Fisar, J; Holub, M; Lemez, P; Maresová, J; Slavícek, L; Stejskal, J; Svítil, P; Vásová, I | 1 |
Cassell, PC; Ellis, H; Evans, MG; Gilbert, JM; Hellmann, K; Stoodley, BJ; Wastell, C | 1 |
Lemez, P; Maresová, J | 1 |
Hellmann, K; James, SE; Jones, S; Macdonald, E; Newton, KA; Ryall, RD | 1 |
2 trial(s) available for razoxane and Recrudescence
Article | Year |
---|---|
[Dexrazoxane in patients with B-lymphomas or acute leukemias in the 2nd complete remission enables further therapy with cardiotoxic anthracyclines over recommended cumulative doses].
Topics: Acute Disease; Adult; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiotonic Agents; Female; Heart; Humans; Leukemia, Myeloid; Lymphoma, B-Cell; Male; Middle Aged; Razoxane; Recurrence; Remission Induction | 2004 |
A controlled prospective trial of adjuvant razoxane in resectable colorectal cancer.
Topics: Clinical Trials as Topic; Colonic Neoplasms; Fluorouracil; Humans; Piperazines; Razoxane; Rectal Neoplasms; Recurrence; Semustine; Vincristine | 1981 |
3 other study(ies) available for razoxane and Recrudescence
Article | Year |
---|---|
[Dexrazoxane and cardiotoxicity in repeatedly treated patients].
Topics: Acute Disease; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiotonic Agents; Heart; Humans; Leukemia, Myeloid; Lymphoma, B-Cell; Razoxane; Recurrence | 2004 |
Protective effects of cardioxane against anthracycline-induced cardiotoxicity in relapsed acute myeloid leukemias.
Topics: Acute Disease; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiovascular Agents; Cytarabine; Daunorubicin; Female; Heart; Humans; Leukemia, Myeloid; Male; Middle Aged; Razoxane; Recurrence | 1996 |
Comparison of radiotherapy with and without razoxane (ICRF 159) in the treatment of soft tissue sarcomas.
Topics: Adult; Aged; Female; Humans; Leukopenia; Male; Middle Aged; Piperazines; Radiotherapy, High-Energy; Razoxane; Recurrence; Remission, Spontaneous; Sarcoma; Soft Tissue Neoplasms | 1978 |